472
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Pregnancy outcomes in substance-misusing pregnant women: A 10-year retrospective study

, &

References

  • Angeles DM, Ashwal S, Wycliffe ND, Ebner C, Fayard, E, Sowers L, Holshouser BA. 2007. Relationship between Opioid Therapy, Tissue Damaging Procedures and Brain Metabolites as measured by Proton MRS in asphyxiated term neonates. Paediatric Research 61:614–621.
  • Bada HS, Das A, Bauer C, Shankaran S, Lester B, Wright L, et al. 2002. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstetrics and Gynaecology 100:916–924.
  • Black KI, Stephens C, Haber PS, Lintzseris N. 2012. Unplanned Pregnancy and Contraceptive use in Women attending drug treatment services. Australian and New Zealand Journal of Obstetrics and Gynaecology 52:146–150.
  • Census of population and housing in Malta. Malta: Central Office of Statistics: 2012.
  • Cleary BJ, Donnelly JM, Strawbridge JD, Gallagher PJ, Fahey T, White MJ, Murphy DJ. 2011. Methadone and perinatal outcomes: a retrospective cohort study. American Journal of Obstetrics and Gynaecology 204:139. 1–9.
  • Doggett C, Burrett S, Osborn DA. 2005. Home visits during pregnancy and after birth for women with an alcohol or drug problem. Cochrane Database Systemic Review (4): CD004456
  • EMCDDA (European Monitoring Centre for Drugs and Drug Addiction). 2012. Pregnancy, Childcare and the Family: Key issues for Europe's Response to Drugs. Luxembourg: Publications Office of the European Union.
  • Finnegan L, Pacini M, Maremmani I. 2010. Methadone treatment for pregnant heroin addicted women. Heroin Addiction & related clinical problems 12: 29–36.
  • Fischer G, Kopf N. 2007. Review of the literature on pregnancy and psychosocially assisted pharmacotherapy of opioid dependence. Background document prepared for third Meeting of technical development group (TDG) for the WHO “Guidelines for psychosocially assisted Pharmacotherapy of Opioid Dependence” Geneva Switzerland.
  • Grönbladh L, Öhlund, LS. 2011. Self-reported differences in side-effects for 110 heroin addicts during opioid addiction and during methadone treatment. Heroin Addiction and Related Clinical Problems 13:5–12.
  • Gyarmathy VA, Giraudon I, Hedrich D, Montanari L, Guarita B, Wiessing L. 2009. Drug use and Pregnancy- Challenges for Public Health. Euro surveillance 14:9.
  • Igboekwu J, Wolff K. 2010. Methadone maintenance therapy and feto- maternal outcomes of pregnancy. Heroin Addict Related Clinical Problems 12:17–22.
  • Jansson LM, Velez M, Harrow C. 2004. Methadone maintenance and lactation: a review of the literature and current management guidelines. Journal of human lactation 20:62–71.
  • Jones GL, Haddrill R, Mitchell C, Anumba DA. 2011. Why do women attend late for antenatal booking? A qualitative interview study exploring the perspectives of service users and stakeholders. Journal of Epidemiology and Community Health 65:A4.
  • MacCarthy JJ, Posey BL. 2000. Methadone levels in human milk. Journal of human lactation 16:115–120.
  • Minnes S, Lang A, Singer L. 2011. Prenatal tobacco, Marijuana, Stimulant and Opiate Exposure: Outcomes and Practice Implications. Addiction Science & Clinical Practice 6:57–70.
  • Minozzi S, Amato L, Vecchi S, Davoli M. 2008. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Systemic Review (2):CD006318.
  • O’Connor AB, Collett A, Alto WA, O’Brien LM. 2013. Breast feeding rates and the relationship between breastfeeding and Neonatal abstinence syndrome in women maintained on Buprenorphine during pregnancy. Journal of Midwifery and Women's Health 58:383–388.
  • Pritham UA. 2013. Breast feeding promotion for management of neonatal abstinence syndrome. Journal of Obstetrics and Gynaecology and Neonatology Nursing 42: 517–526.
  • Rini CK, Dunkel-Schetter C, Wadhwa PD, Sandman CA, 1999. Psychological Adaptation and Birth Outcomes: The Role of Personal Resources, Stress, and Socio cultural Context in Pregnancy. Health Psychology 18, 4:333–345.
  • Roberts J (chairperson). 2003. Scottish Executive. Good Practice Guidance for working with Children and Families affected by Substance Misuse. Appendix III: Substance Misuse in Pregnancy
  • Savona-Ventura C. 2004. Pregnancy in Maltese drug-abusers: a socio-biological study. European Journal of Obstetrics and Gynaecology and Reproductive Biology 115:161–165.
  • Simpson WA. 1957. A Preliminary Report on Cigarette Smoking and the Incidence of Prematurity. Obstetrical & Gynaecological Survey: December: 12:6:868–869.
  • Terplan M, Lui S. 2007. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database Systemic Review (4):CD006037
  • Thangappah RBP. 2000. Maternal and perinatal outcome with drug abuse in pregnancy. Journal of Obstetrics and Gynaecology. 20, 6, 697–600.
  • Wolff K, Boys A, Hay AWM, Raistrick D.2005. Changes in Clearance during Pregnancy,European Journal Clinical Pharmacology 61:763–768. Online publication available October 29 2005
  • Wright A, Walker J. 2007. Management of women who use drugs during pregnancy. Seminars in Foetal and Neonatal Medicine 12: 114–118.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.